Anomaly Bio

Anomaly Bio is a Singapore-based biotechnology company that utilizes synthetic biology, advanced fermentation, and strain engineering to produce bio-based ingredients. By designing optimized metabolic pathways, the company engineers microorganisms to transform readily available feedstocks, such as sugars, into high-value molecules. This approach turns microbes into efficient micro-factories, offering a scalable and on-demand alternative to traditional, extraction-based manufacturing methods. The company focuses on developing next-generation inputs for industries including crop protection, nutrition, and personal care.

By replacing fragile, legacy supply chains with localized and resilient biomanufacturing capabilities, Anomaly Bio aims to redefine the production of essential ingredients. This technology provides a viable, sustainable manufacturing solution that can be deployed globally to support various trade networks. The company has secured significant pre-seed funding to expand its R&D team in metabolic engineering and to establish its own laboratory and pilot-scale production facilities in Singapore.